鳥居薬品の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2025/06/13 | 6,340 | 6,350 | 6,340 | 6,340 | ±0 | ±0% | 34,200 |
| 2025/06/12 | 6,340 | 6,350 | 6,330 | 6,340 | ±0 | ±0% | 92,500 |
| 2025/06/11 | 6,340 | 6,350 | 6,340 | 6,340 | ±0 | ±0% | 37,300 |
| 2025/06/10 | 6,340 | 6,350 | 6,330 | 6,340 | ±0 | ±0% | 94,300 |
| 2025/06/09 | 6,340 | 6,350 | 6,330 | 6,340 | ±0 | ±0% | 121,000 |
| 2025/06/06 | 6,340 | 6,340 | 6,330 | 6,340 | +10 | +0.2% | 47,900 |
| 2025/06/05 | 6,340 | 6,350 | 6,330 | 6,330 | ±0 | ±0% | 404,600 |
| 2025/06/04 | 6,330 | 6,340 | 6,330 | 6,330 | ±0 | ±0% | 121,000 |
| 2025/06/03 | 6,340 | 6,340 | 6,330 | 6,330 | -10 | -0.2% | 87,700 |
| 2025/06/02 | 6,330 | 6,340 | 6,330 | 6,340 | ±0 | ±0% | 40,800 |
| 2025/05/30 | 6,330 | 6,340 | 6,330 | 6,340 | +10 | +0.2% | 61,300 |
| 2025/05/29 | 6,330 | 6,340 | 6,330 | 6,330 | ±0 | ±0% | 70,000 |
| 2025/05/28 | 6,340 | 6,340 | 6,330 | 6,330 | -10 | -0.2% | 47,900 |
| 2025/05/27 | 6,340 | 6,340 | 6,330 | 6,340 | ±0 | ±0% | 60,000 |
| 2025/05/26 | 6,340 | 6,340 | 6,330 | 6,340 | +10 | +0.2% | 89,900 |
| 2025/05/23 | 6,340 | 6,340 | 6,330 | 6,330 | ±0 | ±0% | 87,200 |
| 2025/05/22 | 6,340 | 6,340 | 6,330 | 6,330 | -10 | -0.2% | 49,800 |
| 2025/05/21 | 6,330 | 6,340 | 6,330 | 6,340 | +10 | +0.2% | 122,800 |
| 2025/05/20 | 6,330 | 6,340 | 6,330 | 6,330 | ±0 | ±0% | 150,200 |
| 2025/05/19 | 6,330 | 6,340 | 6,330 | 6,330 | ±0 | ±0% | 121,700 |
| 2025/05/16 | 6,330 | 6,340 | 6,330 | 6,330 | -10 | -0.2% | 98,000 |
| 2025/05/15 | 6,330 | 6,340 | 6,330 | 6,340 | ±0 | ±0% | 166,700 |
| 2025/05/14 | 6,330 | 6,340 | 6,330 | 6,340 | ±0 | ±0% | 277,000 |
| 2025/05/13 | 6,330 | 6,340 | 6,330 | 6,340 | +10 | +0.2% | 206,400 |
| 2025/05/12 | 6,330 | 6,340 | 6,330 | 6,330 | ±0 | ±0% | 526,000 |
| 2025/05/09 | 6,340 | 6,350 | 6,330 | 6,330 | -10 | -0.2% | 950,900 |
| 2025/05/08 | 6,350 | 6,350 | 6,330 | 6,340 | +760 | +13.6% | 3,056,000 |
| 2025/05/07 | 5,230 | 5,580 | 5,030 | 5,580 | +350 | +6.7% | 670,400 |
| 2025/05/02 | 5,020 | 5,250 | 4,960 | 5,230 | +380 | +7.8% | 564,700 |
| 2025/05/01 | 4,680 | 4,890 | 4,610 | 4,850 | +170 | +3.6% | 317,200 |
| 2025/04/30 | 4,440 | 4,690 | 4,400 | 4,680 | +340 | +7.8% | 315,600 |
| 2025/04/28 | 4,430 | 4,490 | 4,285 | 4,340 | -95 | -2.1% | 263,000 |
| 2025/04/25 | 4,355 | 4,450 | 4,330 | 4,435 | -50 | -1.1% | 258,200 |
| 2025/04/24 | 4,530 | 4,535 | 4,445 | 4,485 | -25 | -0.6% | 94,100 |
| 2025/04/23 | 4,510 | 4,540 | 4,475 | 4,510 | ±0 | ±0% | 104,400 |
| 2025/04/22 | 4,500 | 4,550 | 4,460 | 4,510 | -5 | -0.1% | 112,700 |
| 2025/04/21 | 4,495 | 4,515 | 4,470 | 4,515 | +15 | +0.3% | 103,300 |
| 2025/04/18 | 4,415 | 4,500 | 4,380 | 4,500 | +120 | +2.7% | 113,300 |
| 2025/04/17 | 4,280 | 4,380 | 4,280 | 4,380 | +105 | +2.5% | 101,600 |
| 2025/04/16 | 4,320 | 4,335 | 4,245 | 4,275 | -25 | -0.6% | 40,600 |
| 2025/04/15 | 4,300 | 4,360 | 4,295 | 4,300 | +35 | +0.8% | 47,600 |
| 2025/04/14 | 4,285 | 4,310 | 4,250 | 4,265 | +35 | +0.8% | 33,600 |
| 2025/04/11 | 4,255 | 4,255 | 4,165 | 4,230 | -65 | -1.5% | 58,000 |
| 2025/04/10 | 4,260 | 4,330 | 4,210 | 4,295 | +190 | +4.6% | 87,200 |
| 2025/04/09 | 4,155 | 4,170 | 4,045 | 4,105 | -120 | -2.8% | 103,500 |
| 2025/04/08 | 4,250 | 4,270 | 4,185 | 4,225 | +100 | +2.4% | 49,100 |
| 2025/04/07 | 3,795 | 4,235 | 3,795 | 4,125 | -230 | -5.3% | 193,400 |
| 2025/04/04 | 4,430 | 4,430 | 4,295 | 4,355 | -100 | -2.2% | 92,100 |
| 2025/04/03 | 4,210 | 4,460 | 4,210 | 4,455 | -50 | -1.1% | 181,900 |
| 2025/04/02 | 4,595 | 4,615 | 4,480 | 4,505 | -65 | -1.4% | 77,100 |
1～
50
件表示中 / 3720件
類似銘柄と比較する
現在ご覧いただいている「鳥居薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 鳥居薬 | 634,000円 | +7.1% | -35.0% | 0.00% | 52.43倍 | 1.47倍 |
|
ＪＴ傘下。柱の抗ＨＩＶ薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
| キッセイ薬 | 418,000円 | +3.6% | +6.1% | 2.87% | 14.08倍 | 0.83倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
| ジーエヌアイ | 367,500円 | +21.7% | +999.9% | 0.00% | 15.40倍 | 5.09倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
| 科研薬 | 385,500円 | -6.4% | -71.8% | 4.93% | 42.93倍 | 0.96倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の２本柱。後発品も展開 |
| 東和薬品 | 295,900円 | +7.9% | -3.3% | 2.70% | 8.23倍 | 0.85倍 |
|
後発医薬品メーカーで国内２強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
市場注目の銘柄
チャート関連のコラム
